W STRATEGIES, LLC for GLAXOSMITHKLINE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2017 Labor/HHS appropriations bill with respect to ADAP and vaccines. Education about the importance of vaccines, especially in the adult population.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and changes to copay structure for low income beneficiaries. March 2016 CMS proposed rule implementing a new Part B drug payment program. H.R.5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
H.R.6: 21st Century Cures Act. H.R. 3299: Strengthening Public Health Emergency Response Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.